|
Real-time Estimate
Cboe BZX
22:42:52 01/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.855 USD | -9.95% |
|
-3.39% | -74.80% |
| 08-31 | Karyopharm Therapeutics Submits Supplemental New Drug Application to the Fda for Xpovio Plus Ruxolitinib for Patients with Myelofibrosis | CI |
| 08-29 | Karyopharm Therapeutics Inc. - Special Call |
Chart: Technical Analysis
Stock exchange
Nasdaq
KPTI 1.860 $
-9.71%
2.31M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| KPTI | 1.860USD | -9.71% | 2.31M $ | |
CBOE
| KPTI | 1.855USD | -10.60% | 66.8K $ | |
|
Tradegate
| 25K0 | 1.650EUR | -7.30% | 3.17K € | |
|
Deutsche Boerse AG
| 25K0 | 1.620EUR | +3.85% | 0 € | |
|
Börse Stuttgart
| 25K0 | 1.600EUR | -9.09% | 0 € | |
|
Boerse Muenchen
| 25K0 | 1.620EUR | -10.00% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 3.77 | 4.23 | 4.55 |
| Spread/Res. | -50.80% | -56.15% | -59.23% |
| Spread/Supp. | +2.49% | +2.49% | -0.80% |
| Support | 1.81 | 1.81 | 1.87 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- KPTI Stock
- Charts Karyopharm Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
